Literature DB >> 28737047

The role of mucoactive agents in the mechanically ventilated patient: a review of the literature.

Bradley L Icard1, Edmundo Rubio1.   

Abstract

INTRODUCTION: The management of airway secretions in the mechanically ventilated patient is a routine task throughout all intensive care units. The current treatment strategies are primarily based on anecdotal experiences rather than statistical evidence. Areas covered: This review article evaluates the data from published trials surrounding mucoactive agents and their use in the critically ill patient population. We completed an extensive search through PUBMED and CINAHL via EBSCO, along with the Cochran library to find all trials using mucoactive agents in the critically ill patient population. Expert commentary: Overall, the role of mucoactive agents in the intensive care unit is a field within pulmonary critical care that is in need of evidence-based recommendations. We feel that there is great opportunity for investigators to evaluate different mucoactive therapies in this patient population and to determine their effect on clinical outcomes.

Entities:  

Keywords:  Airway secretions; critically ill; mechanical ventilation; mucoactive agents; mucolytics

Mesh:

Substances:

Year:  2017        PMID: 28737047     DOI: 10.1080/17476348.2017.1359090

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  5 in total

1.  Effects of Different Inhalation Therapy on Ventilator-Associated Pneumonia in Ventilated COVID-19 Patients: A Randomized Controlled Trial.

Authors:  Nikola Delić; Andrija Matetic; Josipa Domjanović; Toni Kljaković-Gašpić; Lenko Šarić; Darko Ilić; Svjetlana Došenović; Josipa Domazet; Ruben Kovač; Frane Runjić; Sanda Stojanović Stipić; Božidar Duplančić
Journal:  Microorganisms       Date:  2022-05-28

2.  Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation: A Randomized Clinical Trial.

Authors:  David M P van Meenen; Sophia M van der Hoeven; Jan M Binnekade; Corianne A J M de Borgie; Maruschka P Merkus; Frank H Bosch; Henrik Endeman; Jasper J Haringman; Nardo J M van der Meer; Hazra S Moeniralam; Mathilde Slabbekoorn; Marcella C A Muller; Willemke Stilma; Bart van Silfhout; Ary Serpa Neto; Hans F M Ter Haar; Jan Van Vliet; Jan Willem Wijnhoven; Janneke Horn; Nicole P Juffermans; Paolo Pelosi; Marcelo Gama de Abreu; Marcus J Schultz; Frederique Paulus
Journal:  JAMA       Date:  2018-03-13       Impact factor: 56.272

3.  Aerosol therapy in relation to retinopathy of prematurity in mechanically ventilated preterm infants.

Authors:  Mei-Chin Yang; Hsiu-Feng Hsiao; Hsiu-Li Tseng; Ya-Wen Chiu; Yi-Hao Weng
Journal:  BMC Pulm Med       Date:  2019-08-13       Impact factor: 3.317

Review 4.  Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey.

Authors:  Bibiche den Hollander; Rosalie S N Linssen; Bart Cortjens; Fardi S van Etten-Jamaludin; Job B M van Woensel; Reinout A Bem
Journal:  Eur J Hosp Pharm       Date:  2020-10-29

5.  Mucoactive agent use in adult UK Critical Care Units: a survey of health care professionals' perception, pharmacists' description of practice, and point prevalence of mucoactive use in invasively mechanically ventilated patients.

Authors:  Mark Borthwick; Danny McAuley; John Warburton; Rohan Anand; Judy Bradley; Bronwen Connolly; Bronagh Blackwood; Brenda O'Neill; Marc Chikhani; Paul Dark; Murali Shyamsundar
Journal:  PeerJ       Date:  2020-05-04       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.